Number: RS21418
Title: Regulation of Plant-Based Pharmaceuticals
Authors: Geoffrey S. Becker, Resources, Science, and Industry Division; and Donna Vogt, Domestic Social Policy Division 
Abstract: Among many genetically engineered crops being developed are a number modified to produce pharmaceutical compounds (none yet commercialized). Proponents say proteins from such plants might be used, for example, to vaccinate against and/or treat various cancers; infectious, cardiovascular, and nervous system diseases; metabolic disorders; and biowarfare agents. Farmers might benefit economically from increased demand for new crop products. But critics see risks, such as potential environmental, food safety, and trade problems. Among the issues is whether the current system for regulating biotechnologyshared by several federal agenciesis adequate and, if not, what types of changes are needed.
Pages: 6
Date: March 8, 2005